IL121755A0 - Pharmaceutical compositions comprising 8,9-dehydroestrone or a salt of its 3-sulfate ester - Google Patents

Pharmaceutical compositions comprising 8,9-dehydroestrone or a salt of its 3-sulfate ester

Info

Publication number
IL121755A0
IL121755A0 IL12175597A IL12175597A IL121755A0 IL 121755 A0 IL121755 A0 IL 121755A0 IL 12175597 A IL12175597 A IL 12175597A IL 12175597 A IL12175597 A IL 12175597A IL 121755 A0 IL121755 A0 IL 121755A0
Authority
IL
Israel
Prior art keywords
dehydroestrone
salt
pharmaceutical compositions
sulfate ester
sulfate
Prior art date
Application number
IL12175597A
Other languages
English (en)
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of IL121755A0 publication Critical patent/IL121755A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IL12175597A 1996-09-16 1997-09-12 Pharmaceutical compositions comprising 8,9-dehydroestrone or a salt of its 3-sulfate ester IL121755A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72867696A 1996-09-16 1996-09-16

Publications (1)

Publication Number Publication Date
IL121755A0 true IL121755A0 (en) 1998-02-22

Family

ID=24927854

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12175597A IL121755A0 (en) 1996-09-16 1997-09-12 Pharmaceutical compositions comprising 8,9-dehydroestrone or a salt of its 3-sulfate ester

Country Status (14)

Country Link
EP (1) EP0829263A1 (ja)
JP (1) JPH10101567A (ja)
KR (1) KR19980024568A (ja)
AU (1) AU3755397A (ja)
BR (1) BR9704710A (ja)
CA (1) CA2215655A1 (ja)
CZ (1) CZ286397A3 (ja)
HU (1) HUP9701542A3 (ja)
ID (1) ID18256A (ja)
IL (1) IL121755A0 (ja)
NZ (1) NZ328739A (ja)
SG (1) SG65684A1 (ja)
SK (1) SK122897A3 (ja)
ZA (1) ZA978305B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3551459A (en) * 1962-10-04 1970-12-29 Herchel Smith 13-methyl-8-isogonanes
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
US5395831A (en) * 1994-04-08 1995-03-07 American Home Products Corporation Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone

Also Published As

Publication number Publication date
MX9706964A (es) 1998-08-30
CZ286397A3 (cs) 1998-03-18
HUP9701542A3 (en) 2000-01-28
AU3755397A (en) 1998-03-19
HU9701542D0 (en) 1997-10-28
JPH10101567A (ja) 1998-04-21
SG65684A1 (en) 1999-06-22
ZA978305B (en) 1999-03-15
BR9704710A (pt) 1998-12-29
CA2215655A1 (en) 1998-03-16
SK122897A3 (en) 1998-04-08
ID18256A (id) 1998-03-19
EP0829263A1 (en) 1998-03-18
HUP9701542A2 (hu) 1998-06-29
NZ328739A (en) 1999-08-30
KR19980024568A (ko) 1998-07-06

Similar Documents

Publication Publication Date Title
ZA957247B (en) Pharmaceutical compositions
ZA969248B (en) New aminoacid derivatives process for the manufacture thereof and pharmaceutical compositions containing thesse compounds
HU9503199D0 (en) Pharmaceutical basic compositions
EG24118A (en) Pharmaceutical compositions
HUP0004071A3 (en) Pharmaceutical compositions comprising prostaglandin derivatives
GB9616672D0 (en) Pharmaceutical compositions
IL113329A0 (en) Benzamide-containing pharmaceutical compositions
GB9418609D0 (en) Pharmaceutical compositions
GB9610359D0 (en) Pharmaceutical compositions
HK1021728A1 (en) Pharmaceutical composition containing 4-oxo-butynic acids
ZA9710919B (en) Pharmaceutical compositions containing N-sulphony-lindole derivatives
ZA954469B (en) Pharmaceutical compositions
ZA979726B (en) Pharmaceutical compositions
GB9606429D0 (en) Pharmaceutical compositions
ZA959081B (en) Pharmaceutical compositions
GB9613457D0 (en) Pharmaceutical compositions
IL121755A0 (en) Pharmaceutical compositions comprising 8,9-dehydroestrone or a salt of its 3-sulfate ester
GB9406835D0 (en) Pharmaceutical compositions
GB2295825B (en) Pharmaceutical compositions
GB9618376D0 (en) Pharmaceutical compositions
HU9601821D0 (en) Pharmaceutical compositions
HU9400096D0 (en) Pharmaceutical compositions
GB9610136D0 (en) Pharmaceutical compositions
GB9707483D0 (en) Pharmaceutical compositions
HUP0001499A3 (en) Use of 7alpha-methyl-17alpha-ethynyl-estrane derivative for producing pharmaceutical compositions for the treatment of atherosclerosis